Novel evidence suggesting an anti-oxidant property for erythropoietin on vancomycin-induced nephrotoxicity in a rat model

Clinical and Experimental Pharmacology and Physiology

Volumn 34, Issue 11, 2007, Pages 1181-1185

  Cetin, Hasan ^a,b   Olgar, Şeref ^b   Oktem, Faruk ^b   Ciris, Metin ^b   Uz, Efkan ^b   Aslan, Çaǧatay ^b   Ozguner, Fehmi ^b  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Erythropoietin; Nephrotoxicity; Oxidative stress; Vancomycin

Indexed keywords

CATALASE; CREATININE; ERYTHROPOIETIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; HISTOPATHOLOGY; MALE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; BLOOD UREA NITROGEN; CATALASE; CREATININE; DISEASE MODELS, ANIMAL; EPOETIN ALFA; KIDNEY; KIDNEY DISEASES; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; VANCOMYCIN;

EID: 34548674676     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04695.x     Document Type: Article

References (35)

1. Rodvold KA, Everett JA, Pryka RD, Kraus DM. Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children. Clin. Pharmacokinet. 1997 33 : 32 51.
2. Nishino Y, Takemura S, Minamiyama Y et al. Inhibition of vancomycin-induced nephrotoxicity by targeting superoxide dismutase to renal proximal tubule cells in the rat. Redox. Rep. 2002 7 : 317 19.
3. Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J. Antimicrob. Chemother. 1996 37 : 209 22.
4. Iwamoto T, Kagawa Y, Kojima M. Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin. Biol. Pharm. Bull. 2003 26 : 876 9.
5. Parlakpinar H, Tasdemir S, Polat A et al. Protective role of caffeic acid phenethyl ester (cape) on gentamycin-induced acute renal toxicity in rats. Toxicology 2005 207 : 169 77.
6. Nishino Y, Takemura S, Minamiyama Y et al. Targeting superoxide dismutase to renal proximal tubule cells attenuates vancomycin-induced nephrotoxicity in rats. Free Radic. Res. 2003 37 : 373 9.
7. Oktem F, Arslan MK, Ozguner F et al. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: Protection by erdosteine. Toxicology 2005 215 : 227 33.
8. Celik I, Cihangiroglu M, Ilhan N, Akpolat N, Akbulut HH. Protective effects of different antioxidants and amrinone on vancomycin-induced nephrotoxicity. Basic Clin. Pharmacol. Toxicol. 2005 97 : 325 32.
9. Beauchamp D, Pellerin M, Gourde P, Pettigrew M, Bergeron MG. Effect of daptomycin and vancomycin on tobramycin nephrotoxicity in rats. Antimicrob. Agents. Chemother. 1990 34 : 139 47.
10. Appel GB, Given DB, Levine LR, Cooper GL. Vancomycin and the kidney. Am. J. Kidney Dis. 1986 8 : 75 80.
11. Inoue M, Nishikawa M, Sato E, Matsuno K, Sasaki J. Synthesis of superoxide dismutase derivative that specifically accumulates in renal proximal tubule cells. Arch. Biochem. Biophys. 1999 368 : 354 60.
12. Nagai T, Akizawa T, Nakashima Y et al. Effects of rHuEpo on cellular proliferation and endothelin-1 production in cultured endothelial cells. Nephrol. Dial. Transplant 1995 10 : 1814 19.
13. Carlini RG, Reyes AA, Rothstein M. Recombinant human erythropoietin stimulates angiogenesis in vitro. Kidney Int. 1995 47 : 740 5.
14. Sharples EJ, Yaqoop MM. Erythropoietin in experimental acute renal failure. Nephron. Exp. Nephrol. 2006 104 : E83 8.
15. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 1999 55 : 808 20.
16. Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J. Am. Soc. Nephrol. 2004 15 : 2115 24.
17. Bagnis C, Beaufils H, Jacquiaud C et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol. Dial. Transplant. 2001 16 : 932 8.
18. Jolley ME, Stroupe SD, Schwenzer KS et al. Fluorescence polarization immunoassay. III. An automated system for therapeutic drug determination. Clin. Chem. 1981 27 : 1575 9.
19. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990 186 : 421 31.
20. Sun Y, Oberley LW, Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988 34 : 497 500.
21. Aebi H. Catalase in vitro. Methods Enzymol. 1984 105 : 121 6.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951 193 : 265 75.
23. Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV. In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int. 1998 53 : 394 401.
24. Erdem A, Gundogan NU, Usubutun A et al. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. Nephrol. Dial. Transplant. 2000 15l : 1175 82.
25. Pedraza-Chaverri J, Maldonado PD, Medina-Campos ON et al. Garlic ameliorates gentamicin nephrotoxicity: Relation to antioxidant enzymes. Free Radic. Biol. Med. 2000 29 : 602 11.
26. Oktem F, Ozguner F, Sulak O et al. Lithium-induced renal toxicity in rats: Protection by a novel antioxidant caffeic acid phenethyl ester. Mol. Cell. Biochem. 2005 277 : 109 15.
27. King DW, Smith MA. Proliferative responses observed following vancomycin treatment in renal proximal tubule epithelial cells. Toxicol. In Vitro 2004 18 : 797 803.
28. Oncu M, Gultekin F, Karaoz E, Altuntas I, Delibas N. Nephrotoxicity in rats induced by chlorpryfos-ethyl and ameliorating effects of antioxidants. Hum. Exp. Toxicol. 2002 21 : 223 30.
29. Vardi N, Parlakpinar H, Ozturk F, Acet A. Gentamicin-induced nephrotoxicity and protective effect of caffeic acid phenethyl ester in rats. Fundam. Clin. Pharmacol. 2005 19 : 173 7.
30. Kumral A, Gonenc S, Acikgoz O et al. Erythropoietin increases glutathione peroxidase enzyme activity and decreases lipid peroxidation levels in hypoxic-ischemic brain injury in neonatal rats. Biol. Neonate 2005 87 : 15 18.
31. Calapai G, Marciano MC, Corica F et al. Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. J. Pharmacol. 2000 401 : 349 56.
32. Ozturk E, Demirbilek S, But AK et al. Antioxidant properties of propofol and erythropoietin after closed head injury in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005 29 : 922 7.
33. Ates E, Yalcin AU, Yilmaz S, Koken T, Tokyol C. Protective effect of erythropoietin on renal ischemia and reperfusion injury. Aust. N.Z. J. Surg. 2005 75 : 1100 5.
34. Spandou E, Tsouchnikas I, Karkavelas G et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol. Dial. Transplant. 2006 21 : 330 6.
35. Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int. 2004 66 : 983 9.